Çiğdem Yılmaz Çolak

Çiğdem Yılmaz Çolak


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
ÇÇÇiğdem Yılmaz Çolak
Çiğdem Yılmaz Çolak

10 April 2023 in Research in Microbiology
Verified
Journal Article
Closed access
EDEda Delik
Eda Delik
BEBerfin Eroğlu
Berfin Eroğlu
ÇÇÇiğdem Yılmaz Çolak
Çiğdem Yılmaz Çolak
AÖAYSUN TÜRKANOĞLU ÖZÇELİK
AYSUN TÜRKANOĞLU ÖZÇELİK
BÖBurcu Emine TEFON ÖZTÜRK
Burcu Emine TEFON ÖZTÜRK

1 September 2022 in Pathogens and Global Health
Verified
Journal Article
Closed access
ÇÇÇiğdem Yılmaz Çolak
Çiğdem Yılmaz Çolak
BÖBurcu Emine TEFON ÖZTÜRK
Burcu Emine TEFON ÖZTÜRK
Bordetella pertussis is the causative agent of a respiratory infection called pertussis (whooping cough) that can be fatal in newborns and infants. The pathogen produces a variety of antigenic compounds which alone or simultaneously can damage various host cells. Despite the availability of pertussis vaccines and high vaccination coverage around the world, a resurgence of the disease has been observed in many countries. Reasons for the increase in pertussis cases may include increased awareness, improved diagnostic techniques, low vaccine efficacy, especially acellular vaccines, and waning immunity. Many efforts have been made to develop more effective strategies to fight against B. pertussis and one of the strategies is the use of outer membrane vesicles (OMVs) in vaccine formulations. OMVs are attracting great interest as vaccine platforms since they can carry immunogenic structures such as toxins and LPS. Many studies have been carried out with OMVs from different B. pertussis strains and they revealed promising results in the animal challenge and human preclinical model. However, the composition of OMVs differs in terms of isolation and purification methods, strains, culture, and stress conditions. Although the vesicles from B. pertussis represent an attractive pertussis vaccine candidate, further studies are needed to advance clinical research for next-generation pertussis vaccines. This review summarizes general information about pertussis, the history of vaccines against the disease, and the immune response to these vaccines, with a focus on OMVs. We discuss progress in developing an OMV-based pertussis vaccine platform and highlight successful applications as well as potential challenges and gaps.

6 January 2024 in In Silico Pharmacology
Verified
Journal Article
Open access
PDF file
ÇÇÇiğdem Yılmaz Çolak
Çiğdem Yılmaz Çolak
Streptococcus uberis is one of the causative agents of bovine mastitis, which has detrimental effects on animal health and the dairy industry. Despite decades of research, the requirement for effective vaccines against the disease remains unmet. The goal of this study was to create a multi-epitope vaccine using five virulence factors of S. uberis through the reverse vaccinology approach, which has been employed due to its high efficiency and applicability. Plasminogen activator A (PauA), glyceraldehyde-3-phosphate dehydrogenase C (GapC), C5a peptidase, S. uberis adhesion molecule (SUAM), and sortase A (SrtA) were selected for the T cytotoxic (CTL) and B cell epitope analyses as they were extensively studied in S. uberis or other pathogens. Eighteen CTL and ten B cell epitopes that were antigenic, non-toxic, and non-allergenic were selected in order to design a chimeric vaccine candidate that in silico analysis revealed to be potentially immunogenic, non-allergenic, and stable. Molecular docking analysis of the vaccine candidate with Toll-like receptor (TLR) 2 and TLR 4 revealed stable interactions between the candidate and the immune receptors. Meanwhile, the stability of the docked complexes was confirmed using normal mode analysis. Additionally, in silico immune simulation of the vaccine candidate demonstrated the stimulation of primary immune responses, indicating that the chimeric protein can hold promise as a viable vaccine candidate for preventing S. uberis mastitis. Moreover, the current study can provide a background for designing epitope-based vaccines based on the explored epitopes.

2 March 2024 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
ÇÇÇiğdem Yılmaz Çolak
Çiğdem Yılmaz Çolak

10 November 2025 in Current Genetics
Verified
Journal Article
Closed access
PDF file
ÇÇÇiğdem Yılmaz Çolak
Çiğdem Yılmaz Çolak